Geron reports preliminary cash of $376.9M as of Dec 31, 2023, ahead of JP Morgan Healthcare Conference

GERON CORP

Cash, cash equivalents, restricted cash, and marketable securities totaled ~$376.9M as of Dec 31, 2023 (preliminary, unaudited).
Geron presenting at 42nd Annual J.P. Morgan Healthcare Conference starting Jan 8, 2024.
Financial close for Q4 and FY2023 not yet completed; estimate subject to change.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.